2012
DOI: 10.7196/samj.6261
|View full text |Cite
|
Sign up to set email alerts
|

Paediatric living donor liver transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 15 publications
(10 reference statements)
0
3
0
Order By: Relevance
“…From 1985 to 2004, 146 children underwent PLT in South Africa, with a reported 5‐year survival of >80% 47 . Some of the barriers to establishing a program described by the South African team included education of medical staff about the prevalence, severity, and treatment of PLD, improving surgical technique, resource shortages, and logistical limitations 47,53 . Last, expertise on the management of patients with concomitant infections such as HIV, HCV, HBV, and TB may be drawn upon from South African transplant colleagues.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…From 1985 to 2004, 146 children underwent PLT in South Africa, with a reported 5‐year survival of >80% 47 . Some of the barriers to establishing a program described by the South African team included education of medical staff about the prevalence, severity, and treatment of PLD, improving surgical technique, resource shortages, and logistical limitations 47,53 . Last, expertise on the management of patients with concomitant infections such as HIV, HCV, HBV, and TB may be drawn upon from South African transplant colleagues.…”
Section: Discussionmentioning
confidence: 99%
“…37 Last, ensuring that rural patients have transportation and are able to manage complications and medications promptly and accurately is important for the success of the LT program. 37 Currently, Kenya performs living-donor kidney transplanta- 53 Last, expertise on the management of patients with concomitant infections such as HIV, HCV, HBV, and TB may be drawn upon from South African transplant colleagues.…”
Section: Con Clus Ionmentioning
confidence: 99%
“…Simultaneously we approached the family for any potential living donors. If a potential living donor was eligible, and no deceased donor graft available, we proceeded with the living donor liver transplant procedure 14,15 . For recipients of ABO‐incompatible grafts, a protocolized treatment plan was followed to achieve and maintain IgG and IgM isoagglutinin titers less than or equal to 1:16 using therapeutic plasmapheresis, the frequency of which was dependent on daily titers, and Rituximab (375 mg/m 2 ) on days 4 and 10 post‐transplant, with standard immunosuppression comprising combination corticosteroid and tacrolimus.…”
Section: Methodsmentioning
confidence: 99%